November 2025. Karolinska Development AB (Nasdaq Stockholm: KDEV) today publishes its Interim Report January-September 2025. The full report is available on the Company's website. “We are now ...
Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback